Regeneron Pharmaceuticals... (REGN)

AI Score

Unlock

602.46

2.70 (0.45%)

At close: Apr 25, 2025, 3:59 PM

603.21

0.13%

After-hours: Apr 25, 2025, 07:41 PM EDT

Regeneron Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	n/a	2.01B	1.93B	2.6B	2.73B	2.15B	1.94B	3.92B	3.11B	3.49B	3.4B	3.35B	2.89B	3.43B	2.07B	1.44B	2.19B	1.57B	1.99B	2.21B	1.62B	1.38B	1.05B	1.71B	1.47B	1.09B	917.88M	1.02B	812.73M	792.07M	744.31M	811.77M	535.2M	920.36M	646.51M	604.21M
Short-Term Investments	17.91B	7.78B	7.89B	7.92B	8.11B	7.76B	6.99B	5.04B	4.64B	3.53B	4.17B	3.7B	2.81B	2.36B	1.84B	2.07B	1.39B	1.45B	1.15B	1.8B	1.6B	1.49B	1.62B	1.52B	1.34B	1.1B	765.64M	605.46M	596.85M	586.88M	523.54M	495.31M	503.48M	488.03M	398.66M	244.97M
Long-Term Investments	-1.14B	8.49B	7.92B	7.06B	5.4B	5.78B	6.33B	6.07B	5.41B	5.97B	6.42B	7.08B	6.84B	5.63B	3.9B	3.54B	3.14B	2.88B	2.59B	3.24B	3.26B	3.11B	2.88B	2.34B	1.75B	1.87B	2.04B	1.82B	1.49B	1.33B	1.06B	967.7M	864.26M	777.91M	589.85M	555.21M
Other Long-Term Assets	n/a	1.04B	797M	388.7M	444.1M	409.9M	393.2M	349.6M	-4.66B	320.2M	-5.56B	262M	555.2M	145.9M	142.9M	145.7M	328.9M	168.8M	175.5M	161.2M	531.8M	137.9M	139.8M	144.3M	370.7M	125.2M	249.27M	78.98M	302.84M	36.62M	36.96M	37.09M	150.82M	20.7M	6.71M	5.79M
Receivables	6.21B	6.11B	5.72B	5.22B	5.67B	5.58B	5.12B	5.12B	5.33B	5.55B	5.16B	4.84B	6.04B	5.45B	7B	4.17B	4.11B	4.04B	2.81B	2.93B	2.67B	2.66B	2.46B	2.31B	2.24B	2.2B	2.04B	1.94B	1.97B	1.97B	1.84B	1.75B	1.61B	1.64B	1.75B	1.87B
Inventory	3.09B	3.02B	2.87B	2.71B	2.58B	2.56B	2.01B	1.87B	2.4B	2.41B	2.22B	1.99B	1.95B	2.05B	1.98B	2.16B	1.92B	1.8B	1.64B	1.48B	1.42B	1.34B	1.32B	1.21B	1.15B	1.04B	928.55M	820.4M	726.14M	641.59M	554.32M	466.58M	399.36M	345.62M	316.07M	303.29M
Other Current Assets	349.2M	412M	681.9M	414.9M	386.6M	574.7M	366.3M	406.2M	n/a	446.4M	583.6M	424.9M	332.4M	482M	444.3M	213.6M	n/a	n/a	n/a	n/a	113.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	224.97M	n/a	n/a	n/a	1.00	n/a	n/a	n/a
Total Current Assets	27.21B	19.33B	19.08B	18.87B	19.48B	18.63B	16.92B	16.91B	22.06B	15.43B	21.36B	14.31B	20.52B	13.78B	13.34B	10.06B	12.75B	9.1B	7.86B	8.64B	10.56B	7.11B	6.65B	6.93B	7.96B	5.72B	6.7B	4.54B	5.6B	4.14B	3.86B	3.67B	3.91B	3.5B	3.21B	3.13B
Property-Plant & Equipment	4.6B	4.44B	4.31B	4.23B	4.15B	4.01B	3.92B	3.88B	3.76B	3.7B	3.64B	3.56B	3.48B	3.4B	3.36B	3.26B	3.22B	3.14B	3.03B	2.94B	2.89B	2.77B	2.68B	2.61B	2.58B	2.52B	2.46B	2.39B	2.36B	2.27B	2.26B	2.28B	2.08B	1.87B	1.77B	1.67B
Goodwill & Intangibles	1.15B	1.12B	1.1B	1.06B	1.04B	1.02B	953M	928.7M	915.5M	804.1M	n/a	n/a	-6.84B	n/a	n/a	n/a	-3.14B	n/a	n/a	n/a	-3.26B	n/a	n/a	n/a	-1.75B	n/a	-2.04B	n/a	-1.49B	n/a	n/a	n/a	-864.26M	n/a	n/a	n/a
Total Long-Term Assets	9.06B	18.11B	17.01B	15.5B	13.6B	13.53B	13.73B	13.15B	7.15B	12.25B	5.84B	12.04B	4.91B	9.9B	8.15B	7.72B	4.41B	6.99B	6.57B	7.11B	4.25B	6.83B	6.52B	5.93B	3.78B	5.09B	3.26B	4.83B	3.17B	4.57B	4.25B	4.15B	3.06B	3.33B	3B	2.77B
Total Assets	37.76B	37.44B	36.09B	34.37B	33.08B	32.16B	30.66B	30.06B	29.21B	27.68B	27.21B	26.35B	25.43B	23.67B	21.49B	17.77B	17.16B	16.08B	14.43B	15.76B	14.81B	13.94B	13.17B	12.85B	11.73B	10.81B	9.95B	9.37B	8.76B	8.7B	8.11B	7.82B	6.97B	6.83B	6.2B	5.9B
Account Payables	789.5M	497.3M	561.7M	671.3M	606.6M	536.6M	547.3M	599.5M	589.2M	535.6M	534.2M	470.3M	564M	427M	476M	542.9M	475.5M	443.1M	380.1M	347.8M	418.1M	335.6M	244M	239.6M	218.2M	172.36M	171.91M	207.61M	178.2M	153.95M	151.37M	141.8M	134.98M	124.5M	101.72M	120.59M
Deferred Revenue	813.4M	627.2M	586M	516.7M	458.9M	417.3M	381.1M	426.3M	547.7M	547.2M	625M	491.3M	442M	507.8M	520M	464.9M	577.7M	494.8M	461.5M	479.2M	591.7M	608.7M	592.4M	530.7M	452.5M	462.94M	488.57M	391.91M	320.14M	319.87M	312.26M	238.42M	231.66M	242.68M	188.22M	172.94M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	719.7M	719M	718.4M	717.8M	n/a	n/a	1.5B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	-1B	2.54B	n/a	n/a	1.74B	111.5M	n/a	n/a	1.58B	n/a	n/a	n/a	2.09B	-719M	-718.4M	-717.8M	n/a	96.9M	103.8M	85M	1.33B	1.9M	4M	6.2M	489.5M	n/a	n/a	n/a	-168.08M	372.1M	395.71M	375.96M	1.18M	298.8M	362.19M	330.53M
Total Current Liabilities	813.4M	3.66B	3.51B	3.58B	3.42B	3.6B	3.1B	3.1B	3.85B	2.88B	4.54B	3.01B	3.45B	3.71B	3.73B	3.22B	2.81B	2.34B	3.7B	2.06B	1.79B	1.77B	1.71B	1.51B	1.35B	1.42B	1.03B	1.27B	967.42M	1.14B	1.03B	1.31B	980.66M	961.18M	951.56M	919.72M
Long-Term Debt	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	1.98B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.75B	1.46B	908.5M	854.1M	832.4M	716.8M	677.3M	638M	598.6M	724.7M	692.5M	680.2M	662.6M	596.3M	571.5M	687.1M	821M	848.2M	772M	395.3M	273M	267.9M	376.3M	546.6M	194.03M	190.02M	169.92M	949.29M	125.22M	115.92M	106.25M	100.39M	135.7M	815.31M	857.42M
Total Long-Term Liabilities	1.98B	4.46B	4.37B	3.8B	3.68B	3.66B	3.54B	3.46B	2.7B	3.36B	1.98B	3.43B	3.21B	2.7B	2.63B	2.58B	3.33B	3.62B	1.67B	1.57B	1.92B	1.67B	1.7B	1.9B	1.63B	1.52B	1.73B	1.54B	1.65B	1.51B	1.56B	1.64B	1.54B	1.38B	1.18B	1.22B
Total Liabilities	2.8B	8.12B	7.88B	7.38B	7.11B	7.26B	6.64B	6.56B	6.55B	6.24B	6.52B	6.43B	6.67B	6.41B	6.36B	5.8B	6.14B	5.96B	5.37B	3.62B	3.72B	3.43B	3.42B	3.41B	2.98B	2.94B	2.77B	2.81B	2.62B	2.65B	2.59B	2.95B	2.52B	2.34B	2.13B	2.14B
Total Debt	1.98B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.7B	2.69B	2.22B	715.2M	713.9M	712.7M	711.3M	709.9M	708.5M	707.2M	705.9M	704.64M	703.45M	702.32M	701.17M	707.61M	481.13M	382.23M	361.52M	362.23M
Common Stock	n/a	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K	112K	112K	112K	112K	111K	111K	110K	110K	109K	109K	109K
Retained Earnings	n/a	30.76B	29.41B	27.98B	27.26B	26.1B	25.09B	24.12B	23.31B	22.11B	20.79B	19.94B	18.97B	16.74B	15.11B	12.01B	10.89B	9.74B	8.9B	8B	7.38B	6.59B	5.92B	5.73B	5.25B	4.43B	3.84B	3.29B	2.95B	2.77B	2.38B	2B	1.75B	1.5B	1.23B	1.02B
Comprehensive Income	-7.9M	60.2M	-69.9M	-77.2M	-80.9M	-176.8M	-197.7M	-181.6M	-238.8M	-275.1M	-223.8M	-170.1M	-26.2M	9.5M	15.7M	16.2M	29.3M	30.8M	35.5M	-9.1M	21.1M	16.5M	15.8M	2.8M	-12.3M	-10.52M	-11.61M	-15.59M	640K	23.84M	2.35M	-5.88M	-12.84M	-2.9M	5.2M	4.36M
Shareholders Equity	34.96B	29.33B	28.21B	26.99B	25.97B	24.9B	24.02B	23.5B	22.66B	21.44B	20.69B	19.91B	18.77B	17.26B	15.13B	11.98B	11.03B	10.13B	9.06B	12.13B	11.09B	10.5B	9.76B	9.44B	8.76B	7.87B	7.19B	6.57B	6.14B	6.05B	5.52B	4.87B	4.45B	4.49B	4.08B	3.77B
Total Investments	17.91B	16.28B	15.81B	14.98B	16.24B	7.76B	6.99B	5.04B	10.04B	9.5B	10.59B	10.79B	9.65B	7.99B	5.74B	5.61B	4.53B	4.33B	3.74B	5.03B	4.85B	4.61B	4.51B	3.86B	3.1B	2.98B	2.81B	2.43B	2.08B	1.91B	1.59B	1.46B	1.37B	1.27B	988.51M	800.17M